Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Green Lifescience Co., Ltd. (114450:KRX), powered by AI.
Green Lifescience Co., Ltd. is currently trading at ₩3,350. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Green Lifescience Co., Ltd. on Alpha Lenz.
Green Lifescience Co., Ltd.'s P/E ratio is 661.9.
“Green Lifescience Co., Ltd. trades at a P/E of 661.9 (premium valuation) with modest ROE of 0.3%.”
Ask for details →Green Lifescience Co., Ltd. is a dynamic player in the biopharmaceutical industry dedicated to developing innovative healthcare solutions. Its primary focus lies in the research and development of cutting-edge diagnostic tools, therapeutic biologics, and pharmaceutical products intended to address significant medical needs. Green Lifescience actively contributes to advancements in the healthcare sector by pioneering new treatments and technology-driven health solutions, backed by rigorous scientific research and clinical trials. The company operates on a global scale, supplying both health professionals and medical institutions with products that enhance patient care. In the financial markets, Green Lifescience Co., Ltd. stands out for its commitment to improving life sciences, which holds importance in fostering growth in both the health sector and associated industries, such as biotechnology and pharmaceuticals.
“Green Lifescience Co., Ltd. trades at a P/E of 661.9 (premium valuation) with modest ROE of 0.3%.”
Ask for details →Green Lifescience Co., Ltd. (ticker: 114450) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $72.9B.
The current price is ₩3,350 with a P/E ratio of 661.93x and P/B of 1.9x.
ROE is 0.30% and operating margin is 0.51%. Annual revenue is $40.3B.